Garantziotis et al. suggested that local activation of pulmonary innate immunity by lipopolysaccharide (LPS) and its receptor TLR4 is sufficient for the development of obliterative bronchiolitis (OB) after lung transplantation in recipient mice [38]. The gene discussed is TLR4; the disease is bronchiolitis obliterans syndrome.